Skip to main content

Advertisement

Log in

Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Tc-99m PMT and Tc-99m GSA can be taken up by hepatocellular carcinoma (HCC), but there has been no report concerning HCC showing accumulation of both of Tc-99m PMT and Tc-99m GSA. In this paper we describe a case of two simultaneously developed HCCs, one of which took up both tracers but the other took up neither of them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shimomura O, Takahashi M, Tsuji A, Takagi Y, Tomiguchi S, Koga Y, et al. Evaluation of hepatic function by hepatobiliary scintigraphy using factor analysis.KAKU IGAKU (Jpn J Nucl Med) 26: 145–153, 1989.

    CAS  Google Scholar 

  2. Gon J, Nakagawa T, Maeda H, Nakamura H, Tashiro T, Matsuoka Y, et al. Evaluation of postoperative hapatobiliary function by deconvolution analysis of hepatobiliary image data by99mTc-N-pyridoxyl-5-methyltryptophan.Radioisotopes 37: 7–14, 1988.

    PubMed  CAS  Google Scholar 

  3. Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver.J Nucl Med 40: 1652–1656, 1999.

    PubMed  CAS  Google Scholar 

  4. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.Am J Gastoenterol 87: 865–870, 1992.

    CAS  Google Scholar 

  5. Hasegawa Y, Nakano S, Ishiguro S, Imaoka S, Sasaki Y, Tanaka S, et al. Comparison of delayed hepatobiliary imaging using99mTc-Sn-N-5-methyltryptophan and67Ga-citrate imaging for diagnosis of hepatocellular carcinoma.Eur J Nucl Med 14: 414–418, 1988.

    Article  PubMed  CAS  Google Scholar 

  6. Saito K, Koizumi K, Abe K, Goto Y, Seki T. Potential for qualitative diagnosis of tumors and tumorous lesions in the liver with Tc-99m-GSA SPECT-correlation with pathological evaluation and MRI findings.Ann Nucl Med 12: 275–280, 1998.

    PubMed  CAS  Google Scholar 

  7. Hasegawa Y, Nakano S, Hiyama T, Sobue T, Yoshida H, Sasaki Y, et al. Relationship of uptake of Technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.J Nucl Med 32: 228–235, 1991.

    PubMed  CAS  Google Scholar 

  8. Azuma-kato M. Tc-99m(Sn)-N-Pyridoxylaminates: A new series of hepatobiliary imaging agents.J Nucl Med 23: 517–524, 1982.

    Google Scholar 

  9. Hasegawa Y, Nakano K, Ibuka T, Hashizume Y, Sasaki S, Imaoka S, et al. Concentration of99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatoma.Eur J Nucl Med 10: 255–258, 1985.

    Article  PubMed  CAS  Google Scholar 

  10. Cavlet X, Pons F, Bruix J, Bru C, Lomena F, Herranz R, et al. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.J Nucl Med 29: 1916–1920, 1988.

    Google Scholar 

  11. Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Porter BA, Ward RE, et al. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.J Nucl Med 26: 1233–1242, 1985.

    PubMed  CAS  Google Scholar 

  12. Wu J, Ishikawa N, Takeda T, Tanaka Y, Pan XQ, Sato M, et al. The functional hepatic volume assessed by99mTc-GSA hepatic scintigraphy.Ann Nucl Med 9: 229–235, 1995.

    Article  PubMed  CAS  Google Scholar 

  13. Kurtaran A, Li S-R, Radere M, Leimer M, Muller C, Pidlich J, et al. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-try-(A14)-insulin visualizes human hepatocellular carcinomas.J Nucl Med 36: 1875–1881, 1995.

    PubMed  CAS  Google Scholar 

  14. Hyodo I, Mizuno M, Yamada G, Tsuji T. Distribution of asialoglycoprotein receptor in human hepatocellular carcinoma.Liver 13: 80–85, 1993.

    PubMed  CAS  Google Scholar 

  15. Matsui O Kadoya M, Kaneyama T, Yoshikawa J, Takashima T, Nakamura Y, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.Radiology 178: 493–497, 1991.

    PubMed  CAS  Google Scholar 

  16. Conway JG, Popp JA, Thurman RG. Microcirculation of hepatic nodules from diethylnitrosamine-treated rats.Cancer Res 45: 3620–3625, 1985.

    PubMed  CAS  Google Scholar 

  17. Yamashita Y, Matsukawa T, Arakawa A, Hatanaka Y, Urata J, Takahashi M. US-guided liver biopsy: predicting the effect of interventional treatment of hepatocellular carcinoma.Radiology 196: 799–804, 1995.

    PubMed  CAS  Google Scholar 

  18. Shimada M, Takenaka K, Kawahara N, Yamamoto K, Shirabe K, Maehara Y, et al. Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopahological factors.Hepatogastroenterology 43: 1159–1164, 1996.

    PubMed  CAS  Google Scholar 

  19. Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.Liver 7: 18–26, 1987.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanabe, Y., Hashimoto, M., Ohuchi, Y. et al. Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions. Ann Nucl Med 14, 485–488 (2000). https://doi.org/10.1007/BF02988296

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02988296

Key words

Navigation